Intranasal Single-Replication Influenza Vector Induces Cross-Reactive Serum and Mucosal Antibodies against SARS-CoV-2 Variants

Current SARS-CoV-2 vaccines provide protection for COVID-19-associated hospitalization and death, but remain inefficient at inhibiting initial infection and transmission. Despite updated booster formulations, breakthrough infections and reinfections from emerging SARS-CoV-2 variants are common. Intr...

Descripció completa

Dades bibliogràfiques

Autors principals:	Michael J. Moser, Lindsay Hill-Batorski, Richard A. Bowen, Sarah M. Matejka, David Marshall, Yoshihiro Kawaoka, Gabriele Neumann, Pamuk Bilsel
Format:	Artigo
Idioma:	Inglês
Publicat:	MDPI AG 2023-06-01
Col·lecció:	Vaccines
Matèries:	influenza SARS-CoV-2 COVID-19 vaccine intranasal mucosal
Accés en línia:	https://www.mdpi.com/2076-393X/11/6/1063
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!